HLA-B*5801 Testing to Prevent Allopurinol Hypersensitivity Syndrome: A Teachable Moment

JAMA Intern Med. 2018 Sep 1;178(9):1260-1261. doi: 10.1001/jamainternmed.2018.3556.

Authors

Cuong Quach¹, Benjamin T Galen²

Affiliations

¹ Albert Einstein College of Medicine and Montefiore Medical Center, Department of Internal Medicine, Residency Training Program, Bronx, New York.
² Albert Einstein College of Medicine and Montefiore Medical Center, Department of Internal Medicine, Division of Hospital Medicine, Bronx, New York.

PMID: 30083702
DOI: 10.1001/jamainternmed.2018.3556

No abstract available

Publication types

Case Reports
Review

MeSH terms

Aged
Allopurinol / adverse effects*
Drug Hypersensitivity Syndrome / diagnosis
Drug Hypersensitivity Syndrome / immunology
Drug Hypersensitivity Syndrome / prevention & control*
Gout Suppressants / adverse effects
HLA-B Antigens / analysis*
HLA-B Antigens / immunology
Humans
Male

Substances

Gout Suppressants
HLA-B Antigens
HLA-B*58:01 antigen
Allopurinol